About Genection
THE GENECTION DIFFERENCE
In order to make personalized molecular medicine a clinical reality, new platforms need to be developed for the delivery of healthcare. Genection's mission seeks to accelerate the adoption process of making personalized molecular medicine a clinical reality by developing new platforms for the delivery of healthcare.
Introducing MyAML. A targeted NGS panel specifically designed with acute myelogenous leukemia in mind. Used to stratify patients in clinical trials, follow sub-clonal architecture longitudinal across clinical trials, and assist oncologists in determining the best care for their patients. With 194 genes, this panel will bring forth a whole new level in understanding leukemias.
The San Diego-based company will serve as the gateway to the Together We Cure, a global initiative aimed at developing treatments for acute myeloid leukemia.
|
|
|
11-50 employees
View all Genection employees
|
|
Biotechnology Research
|
|
San, Diego, CA, US
|
|
2012
|
|
Pediatrics, Pathology, Internal Medicine, Medical Genetics, And Pharmacogenomics
|
Search Genection Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
